Skip to main content

J1790 HCPCS Level II Code: Injection, droperidol, up to 5 mg

Medicare Coverage & Payment

  • CMS short descriptor: Droperidol injection
  • Medicare coverage: Special coverage instructions apply (CMS coverage code D)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 1997

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, droperidol, up to 5 mg is a HCPCS Level II code (J1790). CMS assigns coverage code D — Special coverage instructions apply. Short description: Droperidol injection.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 1982-01-01
    Added to the code set
    Injection, droperidol, up to 5 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $8.12

00143-9514-25 — Droperidol — Hikma Pharmaceuticals USA Inc. (size 2 × qty 25 (UP TO 5 MG per billing unit))

00143-9515-25 — Droperidol — Hikma Pharmaceuticals USA Inc. (size 1 × qty 25 (UP TO 5 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1790 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (23)

  • J1700 — Injection, hydrocortisone acetate, up to 25 mg [Sibling]
  • J1710 — Injection, hydrocortisone sodium phosphate, up to 50 mg [Sibling]
  • J1720 — Injection, hydrocortisone sodium succinate, up to 100 mg [Sibling]
  • J1725 — Injection, hydroxyprogesterone caproate, 1 mg [Sibling]
  • J1726 — Injection, hydroxyprogesterone caproate, (makena), 10 mg [Sibling]
  • J1729 — Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg [Sibling]
  • J1730 — Injection, diazoxide, up to 300 mg [Sibling]
  • J1736 — Injection, meloxicam (delova), 1 mg [Sibling]
  • and 15 more

Change history

  • 1982-01-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1790 in its code family, with their registry titles.

  • J1743 — Injection, idursulfase, 1 mg
  • J1744 — Injection, icatibant, 1 mg
  • J1745 — Injection, infliximab, excludes biosimilar, 10 mg
  • J1746 — Injection, ibalizumab-uiyk, 10 mg
  • J1747 — Injection, spesolimab-sbzo, 1 mg
  • J1748 — Injection, infliximab-dyyb (zymfentra), 10 mg
  • J1749 — Injection, iloprost, 0.1 mcg
  • J1750 — Injection, iron dextran, 50 mg
  • J1756 — Injection, iron sucrose, 1 mg
  • J1786 — Injection, imiglucerase, 10 units